2016 Partnerships in Clinical Trials (PCT), part of Boston Biotech Week, took place from 5th – 7th October 2016 and was a chance to learn about the Biologic opportunity. As per reports in the public domain at the time, a huge market opportunity lay ahead for Biosimilar developers, with Biologics with sales worth $ 100 Billion going off patent by 2020*
Over 3700 developers were in the race to develop Biosimilar / Biobetter.*
Over 1357 Biosimilar / Biobetter in pipeline*
The demand for comparator drug had been estimated as 500,000 units for phase I trial alone!!!
Can US markets alone supply this quantity to the developers ?
Have you arranged your comparator drug source yet ?
Don’t let the humble comparator drug derail your Billion dollar dreams !
Dr. Piyush Gupta presented “Little known fact about comparator sourcing from Emerging markets” on 5th October 2016 at the 2016 PCT Emerging Market Session at 3:30 pm.
Read the white paper
Comparator sourcing from Emerging Markets and associated cost savings.
For current service information, see comparator sourcing for clinical trials.
Meeting us at PCT
GNH USA's representative was at the PCT loft, Booth 21.
For enquiries, email us: [email protected]